MarketCap
Facebook
X
TelegramQuidel Corporation Total Assets 2011-2026 | QDEL
Total Assets — these are all the resources owned by the business that have economic value. They are used to operate the business, generate profit, and ensure the company’s stability.Main categories of assets
Current assets (used within one year):
- Cash and cash equivalents
- Accounts receivable (amounts owed by customers)
- Inventory of goods, raw materials, and supplies
- Short-term investments
- Fixed assets (buildings, machinery, equipment)
- Intangible assets (brands, patents, software)
- Long-term investments
- Goodwill (reputational value from mergers)
Assets represent an objective measure of a business's value, reflecting everything behind it: physical infrastructure, technology, customer base, and financial resources. A high share of liquid assets such as cash indicates a company’s financial flexibility and its ability to maintain stability in changing market conditions.
Asset analysis helps assess how effectively a company utilizes its resources to generate revenue and profit, reflecting its operational efficiency and ability to convert invested capital into financial results.
Annual Total Assets Quidel Corporation
| 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | 2014 | 2013 | 2012 | 2011 |
|---|---|---|---|---|---|---|---|---|---|
| 1.87 B | 911 M | 806 M | 935 M | 388 M | 407 M | 452 M | 271 M | 242 M | 279 M |
All numbers in USD currency
Indicator range from annual reports
| Maximum | Minimum | Average |
|---|---|---|
| 1.87 B | 242 M | 656 M |
Total Assets of other stocks in the Diagnostics research industry
| Issuer | Total Assets | Price | % 24h | Market Cap | Country | |
|---|---|---|---|---|---|---|
 |
Centogene N.V.
CNTG
|
77.2 M | - | -6.23 % | $ 30.6 M |  Germany |
|
Akumin
AKU
|
1.77 B | - | -17.87 % | $ 25.9 M |  Canada |
 |
Anixa Biosciences
ANIX
|
16.1 M | $ 3.03 | -2.26 % | $ 98.3 K |  USA |
 |
Aspira Women's Health
AWH
|
17.4 M | - | -6.19 % | $ 10.5 M | USA |
 |
Brainsway Ltd.
BWAY
|
94.3 M | $ 23.35 | -2.91 % | $ 99.4 M |  Israel |
 |
Burning Rock Biotech Limited
BNR
|
2.28 B | $ 34.5 | 2.16 % | $ 371 M |  China |
 |
Biocept
BIOC
|
30.9 M | - | -13.05 % | $ 7.29 M | USA |
 |
Accelerate Diagnostics
AXDX
|
65 M | - | -61.36 % | $ 2.46 M | USA |
 |
BioNano Genomics
BNGO
|
76.7 M | $ 1.29 | -12.26 % | $ 1.64 M | USA |
 |
Check-Cap Ltd.
CHEK
|
377 K | - | - | $ 9.42 M | Israel |
 |
Oxford Immunotec Global PLC
OXFD
|
235 M | - | - | $ 562 M |  Britain |
 |
Chembio Diagnostics
CEMI
|
62.6 M | - | 0.22 % | $ 16.8 M | USA |
 |
Co-Diagnostics
CODX
|
95.3 M | - | - | $ 79.8 M | USA |
 |
Castle Biosciences
CSTL
|
531 M | $ 39.74 | 1.48 % | $ 1.1 B | USA |
 |
Danaher Corporation
DHR
|
77.5 B | $ 219.29 | -0.08 % | $ 160 B | USA |
 |
DermTech
DMTK
|
122 M | - | -11.32 % | $ 2.94 M | USA |
 |
Global Cord Blood Corporation
CO
|
8.53 B | - | - | $ 399 M | China |
 |
Fluidigm Corporation
FLDM
|
325 M | - | 1.08 % | $ 308 M | USA |
 |
Genetic Technologies Limited
GENE
|
20.8 M | - | - | $ 7.1 B |  Australia |
 |
Genetron Holdings Limited
GTH
|
975 M | - | 0.12 % | $ 80.1 M | China |
 |
PRA Health Sciences, Inc.
PRAH
|
4.18 B | - | - | $ 10.7 B | USA |
 |
DexCom
DXCM
|
6.26 B | $ 73.31 | -0.93 % | $ 28.3 B | USA |
 |
CareDx, Inc
CDNA
|
467 M | $ 20.55 | -1.23 % | $ 1.1 B | USA |
 |
Celcuity
CELC
|
245 M | $ 109.48 | -2.35 % | $ 4.32 B | USA |
 |
Exact Sciences Corporation
EXAS
|
5.93 B | $ 102.41 | 0.1 % | $ 19 B | USA |
 |
DarioHealth Corp.
DRIO
|
96.4 M | $ 10.2 | -0.97 % | $ 289 M | Israel |
 |
Enzo Biochem
ENZ
|
85.8 M | - | -8.98 % | $ 14.8 K | USA |
 |
Fulgent Genetics
FLGT
|
1.22 B | $ 26.19 | -0.19 % | $ 792 M | USA |
 |
Guardant Health
GH
|
1.49 B | $ 113.17 | 2.43 % | $ 13.9 B | USA |
 |
HTG Molecular Diagnostics
HTGM
|
17.8 M | - | -20.0 % | $ 1.06 M | USA |
 |
Heska Corporation
HSKA
|
586 M | - | - | $ 1.31 B | USA |
 |
IDEXX Laboratories
IDXX
|
3.29 B | $ 672.84 | -0.57 % | $ 55.5 B | USA |
 |
Illumina
ILMN
|
6.3 B | $ 144.81 | -3.26 % | $ 23 B | USA |
 |
QIAGEN N.V.
QGEN
|
5.69 B | - | - | $ 10.6 B |  Niderland |
 |
IQVIA Holdings
IQV
|
26.9 B | $ 230.33 | -2.19 % | $ 41.8 B | USA |
 |
Charles River Laboratories International
CRL
|
7.53 B | $ 210.51 | -0.59 % | $ 10.8 B | USA |
 |
Lantheus Holdings
LNTH
|
1.98 B | $ 66.91 | 0.34 % | $ 4.63 B | USA |
 |
Quest Diagnostics Incorporated
DGX
|
16.2 B | $ 186.45 | 2.27 % | $ 20.7 B | USA |
|
Biodesix
BDSX
|
97.2 M | $ 10.11 | 4.66 % | $ 1.31 B | USA |
 |
Precipio
PRPO
|
18.1 M | $ 24.07 | -0.78 % | $ 31.2 M | USA |
 |
Laboratory Corporation of America Holdings
LH
|
18.4 B | $ 271.34 | 0.56 % | $ 22.8 B | USA |
 |
ICON Public Limited Company
ICLR
|
16.9 B | $ 181.44 | -2.39 % | $ 15 B |  Irlanda |
 |
Medpace Holdings
MEDP
|
2.1 B | $ 582.66 | -1.76 % | $ 18 B | USA |
 |
Koninklijke Philips N.V.
PHG
|
29 B | $ 28.66 | -2.02 % | $ 20 B | Niderland |
 |
Agilent Technologies
A
|
10.7 B | $ 133.33 | 0.07 % | $ 40.5 B | USA |
 |
Biomerica
BMRA
|
5.94 M | $ 2.41 | 0.84 % | $ 5.54 M | USA |
 |
OpGen
OPGN
|
9.86 M | - | -16.95 % | $ 1.54 M | USA |
 |
Bioventus
BVS
|
811 M | $ 7.86 | 0.51 % | $ 492 M | USA |
 |
Motus GI Holdings
MOTS
|
7.22 M | - | -34.28 % | $ 263 K | Israel |